Pelacarsen Heart Drug Fails Despite 78% Cholesterol Cut
A landmark trial has delivered a sobering result for heart medicine: a drug that cut a risky cholesterol marker by 78% did not prevent a single extra heart attack or stroke.
By: hammadkhaksarADاشتہار / AdvertisementGoogle Ad
#pelacarsen
2 articles found under this topic
Heart Drug Slashed ‘Bad Fat’ 78% But Saved No Lives
Pelacarsen cut the heart-risk particle Lp(a) by 78% in more than 8,300 patients, yet prevented no heart attacks or strokes, researchers reported on Saturday.
By: hammadkhaksar